Page last updated: 2024-10-29

imipramine and Apraxias

imipramine has been researched along with Apraxias in 2 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Apraxias: A group of cognitive disorders characterized by the inability to perform previously learned skills that cannot be attributed to deficits of motor or sensory function. The two major subtypes of this condition are ideomotor (see APRAXIA, IDEOMOTOR) and ideational apraxia, which refers to loss of the ability to mentally formulate the processes involved with performing an action. For example, dressing apraxia may result from an inability to mentally formulate the act of placing clothes on the body. Apraxias are generally associated with lesions of the dominant PARIETAL LOBE and supramarginal gyrus. (From Adams et al., Principles of Neurology, 6th ed, pp56-7)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
GAL, JC1
SIGWALD, J1

Other Studies

2 other studies available for imipramine and Apraxias

ArticleYear
[Study of the action of imipramine on parkinsonian akinesia].
    Gazette des hopitaux civils et militaires de l'Empire ottoman, 1960, Sep-25, Volume: 67

    Topics: Apraxias; Imipramine; Parkinson Disease; Psychopharmacology

1960
[Treatment of parkinsonian akinesia].
    La Semaine des hopitaux: therapeutique, 1961, Volume: 37

    Topics: Apraxias; Humans; Imipramine; Iproniazid; Monoamine Oxidase Inhibitors; Parkinson Disease

1961